Evasc Neurovascular announces new generation of eCLIPs bifurcation flow diverter

777

Evasc Neurovascular has announced the third generation of the eCLIPs device. The device is innovated for more effective treatment of intracranial bifurcation aneurysms, facilitating treatment for a wider range of aneurysms with shorter delivery times.

The new device is classified as a flow diverter, with a leaf density of 35%, which is 60% higher than the existing eCLIPs devices. As a result, the new eCLIPs bifurcation flow diverter does not require coiling and provides for the same unique neck bridging delivery. The new eCLIPs bifurcation flow diverter can cover up to a 6mm neck length. The eCLIPs bifurcation flow diverter also simplifies deployment with greatly reduced delivery times. 

The third generation of Evasc’s eCLIPs device, the eCLIPs Bifurcation Flow Diverter.

“We are excited to see the latest innovation in Evasc Neurovascular’s eCLIPs devices, which will lead to better outcomes for patients and remarkable device delivery time—usually within 10 minutes,” said Leif Sorensen (Aarhus University Hospital, Aarhus, Denmark).  

The newest generation of eCLIPs is innovated for more effective treatment of intracranial bifurcation aneurysms with a shapeable delivery wire, a smaller size that is compatible with 0.021” and 0.027” ID microcatheters, and electrolytic detachment. 

“We have listened to the experts in the neuro field and developed an improved version that is smaller and easier to use. This will allow treatment for a wider range of aneurysms and shorten delivery times,” said Donald Ricci, president, and chief executive officer, Evasc Neurovascular.  

“The previous version showed exceptional outcome due to the eCLIPs implant’s ability to bridge the neck of the aneurysm and to create a flow diversion effect. This new and improved version retains these favourable characteristics and also allows eCLIPs to gain access to smaller and more distant vessels within the cerebral anatomy,” added Ricci.


LEAVE A REPLY

Please enter your comment!
Please enter your name here